183 related articles for article (PubMed ID: 31798766)
1. Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-β from growth suppressor to growth and metastasis promoter through TMEPAI/PMEPA1 in triple negative breast cancer.
Singha PK; Pandeswara S; Geng H; Lan R; Venkatachalam MA; Dobi A; Srivastava S; Saikumar P
Genes Cancer; 2019; 10(5-6):134-149. PubMed ID: 31798766
[TBL] [Abstract][Full Text] [Related]
2. TGF-β induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer.
Singha PK; Pandeswara S; Geng H; Lan R; Venkatachalam MA; Saikumar P
Genes Cancer; 2014 Sep; 5(9-10):320-36. PubMed ID: 25352949
[TBL] [Abstract][Full Text] [Related]
3. TGF-β-Induced TMEPAI Promotes Epithelial-Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration.
Wardhani BWK; Louisa M; Watanabe Y; Setiabudy R; Kato M
Breast Cancer (Dove Med Press); 2021; 13():529-538. PubMed ID: 34584450
[TBL] [Abstract][Full Text] [Related]
4. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.
Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S
J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487
[TBL] [Abstract][Full Text] [Related]
5. TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.
Wardhani BW; Puteri MU; Watanabe Y; Louisa M; Setiabudy R; Kato M
J Exp Pharmacol; 2020; 12():17-26. PubMed ID: 32158279
[TBL] [Abstract][Full Text] [Related]
6. Cooperative induction of transmembrane prostate androgen induced protein TMEPAI/PMEPA1 by transforming growth factor-β and epidermal growth factor signaling.
Azami S; Vo Nguyen TT; Watanabe Y; Kato M
Biochem Biophys Res Commun; 2015 Jan; 456(2):580-5. PubMed ID: 25482449
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta (TGF-beta)-inducible gene TMEPAI converts TGF-beta from a tumor suppressor to a tumor promoter in breast cancer.
Singha PK; Yeh IT; Venkatachalam MA; Saikumar P
Cancer Res; 2010 Aug; 70(15):6377-83. PubMed ID: 20610632
[TBL] [Abstract][Full Text] [Related]
8. TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells.
Vo Nguyen TT; Watanabe Y; Shiba A; Noguchi M; Itoh S; Kato M
Cancer Sci; 2014 Mar; 105(3):334-41. PubMed ID: 24438557
[TBL] [Abstract][Full Text] [Related]
9. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling.
Watanabe Y; Itoh S; Goto T; Ohnishi E; Inamitsu M; Itoh F; Satoh K; Wiercinska E; Yang W; Shi L; Tanaka A; Nakano N; Mommaas AM; Shibuya H; Ten Dijke P; Kato M
Mol Cell; 2010 Jan; 37(1):123-34. PubMed ID: 20129061
[TBL] [Abstract][Full Text] [Related]
10. TMEPAI/PMEPA1 Is a Positive Regulator of Skeletal Muscle Mass.
Hagg A; Kharoud S; Goodchild G; Goodman CA; Chen JL; Thomson RE; Qian H; Gregorevic P; Harrison CA; Walton KL
Front Physiol; 2020; 11():560225. PubMed ID: 33250771
[TBL] [Abstract][Full Text] [Related]
11. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
[TBL] [Abstract][Full Text] [Related]
12. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of transcriptional regulation of Meox1 by transforming growth factor β (1) and its effect on cell migration of adult human dermal fibroblasts].
Wei ZY; Li HS; Zhou JY; Han C; Dong H; Wu YZ; He WF; Tian Y; Luo GX
Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):224-233. PubMed ID: 32241049
[No Abstract] [Full Text] [Related]
14. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.
Reka AK; Kurapati H; Narala VR; Bommer G; Chen J; Standiford TJ; Keshamouni VG
Mol Cancer Ther; 2010 Dec; 9(12):3221-32. PubMed ID: 21159608
[TBL] [Abstract][Full Text] [Related]
16. Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
Wahdan-Alaswad R; Harrell JC; Fan Z; Edgerton SM; Liu B; Thor AD
Cell Cycle; 2016; 15(8):1046-59. PubMed ID: 26919310
[TBL] [Abstract][Full Text] [Related]
17. TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells.
Amalia R; Abdelaziz M; Puteri MU; Hwang J; Anwar F; Watanabe Y; Kato M
Cell Signal; 2019 Jul; 59():24-33. PubMed ID: 30890370
[TBL] [Abstract][Full Text] [Related]
18. Requirement of TCF7L2 for TGF-beta-dependent transcriptional activation of the TMEPAI gene.
Nakano N; Itoh S; Watanabe Y; Maeyama K; Itoh F; Kato M
J Biol Chem; 2010 Dec; 285(49):38023-33. PubMed ID: 20889500
[TBL] [Abstract][Full Text] [Related]
19. Implication of Smad2 and Smad3 in transforming growth factor-β-induced posterior capsular opacification of human lens epithelial cells.
Li H; Yuan X; Li J; Tang X
Curr Eye Res; 2015 Apr; 40(4):386-97. PubMed ID: 24911914
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
